Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis
Błażej Misiak, Francesco Bartoli, Filip Stramecki, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 362-370
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Gut Dysbiosis Dysregulates Central and Systemic Homeostasis via Suboptimal Mitochondrial Function: Assessment, Treatment and Classification Implications
George Anderson, Michaël Maes
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 7, pp. 524-539
Closed Access | Times Cited: 89
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Mark R. Libowitz, Erika L. Nurmi
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 61
Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Yutaka Mizuki, Shinji Sakamoto, Yuko Okahisa, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 5, pp. 367-382
Open Access | Times Cited: 62
Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
Błażej Misiak, Bartłomiej Stańczykiewicz, Michał Wiśniewski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110402-110402
Open Access | Times Cited: 48
Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia
Tyler R. Prestwood, Roshanak Asgariroozbehani, Sally Wu, et al.
Behavioural Brain Research (2021) Vol. 402, pp. 113101-113101
Open Access | Times Cited: 39
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 25
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 37
Gut microbiota and microbiome in schizophrenia
Jerzy Samochowiec, Błażej Misiak
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 5, pp. 503-507
Closed Access | Times Cited: 32
Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 39, pp. 4049-4061
Open Access | Times Cited: 28
Unhealthy diet in schizophrenia spectrum disorders
Sophie M. van Zonneveld, Bartholomeus C. M. Haarman, Ellen J. van den Oever, et al.
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 3, pp. 177-185
Open Access | Times Cited: 20
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
Francky Teddy Endomba, Aurel T. Tankeu, Jan René Nkeck, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics
Michał Lis, Bartłomiej Stańczykiewicz, Paweł Liśkiewicz, et al.
Psychoneuroendocrinology (2020) Vol. 119, pp. 104744-104744
Open Access | Times Cited: 28
Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort
Nathalia Garrido-Torres, Miguel Ruiz‐Veguilla, Luis Alameda, et al.
Schizophrenia Research (2022) Vol. 246, pp. 277-285
Open Access | Times Cited: 15
Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
Daniele Cavaleri, Chiara Alessandra Capogrosso, Pierluca Guzzi, et al.
Psychoneuroendocrinology (2023) Vol. 158, pp. 106392-106392
Open Access | Times Cited: 9
Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modelling
Daniele Cavaleri, Aldo De Pietra, Marco Gazzola, et al.
Psychoneuroendocrinology (2024) Vol. 168, pp. 107134-107134
Open Access | Times Cited: 3
Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain
Jing Lü, Manli Huang, Jinhui Li, et al.
Schizophrenia Bulletin (2021) Vol. 47, Iss. 5, pp. 1310-1319
Open Access | Times Cited: 20
Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Dimitrios Patoulias, Theodoros Michailidis, Athina Dimosiari, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 669-669
Open Access | Times Cited: 8
Childhood trauma and glucose metabolism in patients with first-episode psychosis
Sarah Tosato, Chiara Bonetto, Simona Tomassi, et al.
Psychoneuroendocrinology (2019) Vol. 113, pp. 104536-104536
Closed Access | Times Cited: 21
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
Kateřina Horská, Hana Kotolová, Michal Karpíšek, et al.
Toxicology and Applied Pharmacology (2020) Vol. 406, pp. 115214-115214
Closed Access | Times Cited: 15
Orexin/hypocretin and major psychiatric disorders
Chin-Chuen Lin, Tiao‐Lai Huang
Advances in clinical chemistry (2022), pp. 185-212
Closed Access | Times Cited: 10
Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study
Błażej Misiak, Patryk Piotrowski, Jan Aleksander Beszłej, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3822-3822
Open Access | Times Cited: 14
Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of de novo lipogenesis and therapeutic consideration
Mohammad M. Khan, Zaw Ali Khan, Mohsin Ali Khan
World Journal of Psychiatry (2024) Vol. 14, Iss. 6, pp. 767-783
Open Access | Times Cited: 1
Adipose tissue dysregulation at the onset of psychosis: Adipokines and social determinants of health
Franz Veru, Stéphane Guay, Jai Shah, et al.
Psychoneuroendocrinology (2020) Vol. 123, pp. 104915-104915
Open Access | Times Cited: 10
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis
Kazunari Yoshida, Małgorzata Maciukiewicz, Clement C. Zai, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 102, pp. 109952-109952
Closed Access | Times Cited: 8
Assessment of Appetite-Regulating Hormones Provides Further Evidence of Altered Adipoinsular Axis in Early Psychosis
Michał Lis, Bartłomiej Stańczykiewicz, Lilla Pawlik-Sobecka, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top